Related Experiment Video
Updated: Oct 21, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Renal cystic disease in tuberous sclerosis complex
Prashant Kumar1,2, Fahad Zadjali1,2,3, Ying Yao1,2
1Department of Pediatrics, University of Tennessee Health Science Center and Le Bonheur Children's Hospital, Memphis, TN 38105, USA.
Tuberous sclerosis complex (TSC) involves gene mutations leading to mTORC1 pathway overactivation. This review covers TSC kidney disease genetics, cell biology, and the roles of extracellular vesicles and the immune system in its development.
Area of Science:
- Nephrology
- Genetics
- Cell Biology
Background:
- Tuberous sclerosis complex (TSC) is a genetic disorder caused by mutations in TSC1 or TSC2 genes.
- These mutations lead to the hyperactivation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway.
- mTORC1 hyperactivation drives abnormal cell growth and proliferation, manifesting as renal tumors and cysts in TSC patients.
Purpose of the Study:
- To review recent advancements in the nephrology of tuberous sclerosis complex.
- To focus on the genetic and cellular mechanisms underlying TSC-related kidney disease.
- To highlight the involvement of extracellular vesicles and the innate immune system in TSC renal pathogenesis.
Main Methods:
- Literature review of recent research on tuberous sclerosis complex nephrology.
- Analysis of genetic and cell biology studies related to TSC renal disease.
- Synthesis of findings on the role of extracellular vesicles and innate immunity.
Main Results:
- Recent studies have elucidated the genetic underpinnings of TSC renal lesions.
- The role of mTORC1 pathway dysregulation in TSC kidney disease is further detailed.
- Emerging evidence points to extracellular vesicles and innate immune responses as key contributors to disease progression.
Conclusions:
- Understanding the genetics and cell biology of TSC renal disease is crucial for developing targeted therapies.
- Extracellular vesicles and the innate immune system represent novel therapeutic targets for TSC nephropathy.
- Continued research into these pathways will advance the management of kidney complications in tuberous sclerosis complex.
More Related Videos
Related Concept Videos
Urinary Tract Calculi I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Urinary Tract Calculi III: Medical Management
Nephrons
Imaging Studies III: Computed Tomography

